Applications of MRI in Kidney Disease
Key facts
- Who runs it
- University of Minnesota
- Where
- Minneapolis, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 30 Oct 2025
- Expected to end
- 30 Aug 2028
- Type of study
- Observational, 3 groups
- Treatments tested
- No intervention but only observational
- Record updated
- 25 March 2025
- Why it stopped
- due to the risk for the patient and later funding issues
Who can take part
- Age
- 45 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- English-speaking as primary language
- Able to complete an approximately 75 to 90 minute cognitive and/or physical tests
- Capable to consent to studies
Who cannot take part
- Active chemical dependence, such as alcohol, narcotics or other drugs
- Renal transplant recipient at time of screening or baseline
- Acute psychiatric illness that would impede cognitive testing
- Chronic and acute pulmonary disease
- Legally blind or unable to complete cognitive tests due to visual loss or deafness
- Severe CI unable to complete the Modified Mini-Mental State Examination [3MSE]
Where in United States
- University of Minnesota Medical CenterMinneapolis, United States
About the trial
What the trial wants to find out
This study has two major purposes:
Read full original descriptionShow less
1. To test developed multiple anatomic and functional MRI methods; 2. To evaluate the potentials of these MRI methods in the diagnosis, prognosis, and monitoring of the progression of renal dysfunction.
These purposes will be achieved by performing pilot studies with cohorts of patients.
The 3 groups in the trial
- Non-CKD (Control)
Patients without CKD (eGFR ≥ 60 ml/min/1.73 mm2) (non-CKD controls). No intervention but only observational.
Treatment: No intervention but only observational
- CKD (chronic kidney disease)
Patients with Patients with moderate to severe CKD (eGFR ranging from 26 to 44 ml/min/1.73 mm2). No intervention but only observational.
Treatment: No intervention but only observational
- ESRD (end-stage renal disease)
Patients with advanced CKD (eGFR \< 15 ml/min/1.73 mm2), preparing for or undergoing the standard thrice-weekly HD or standard PD treatment (end-stage renal disease (ESRD) patients). No intervention but only observational.
Treatment: No intervention but only observational
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 25 March 2025